Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…
Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage…
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to…
Glioma microenvironment emerges as key target for future therapies
The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and…
Probiotic metabolite found to suppress melanoma tumor growth in mice
Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to respond…
Mount Gambier resident Ben Whitehead in remission after surprise cancer trial results
Ben Whitehead has not stopped smiling since finding out he has entered remission for stage four peripheral T-cell…
Scientists find unexpected immune pathways for mRNA cancer vaccines
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the…
Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma
Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult…
State-run insurance plans for foster kids leave some of them without doctors
Ollie Super has moved in and out of cancer treatment since she was diagnosed with neuroblastoma as a…
Mount Gambier man given three months to live documents battle with rare lymphoma
It was early October 2025 when 49-year-old Ben Whitehead had a sudden change in his health. “In a…
Nanovaccine design boosts immune attack on HPV tumors
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not…
Silica nanomatrix enhances immunotherapy for solid tumors
Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…